AMR Crisis: The Funding Gap & An AMR-Proof Alternative? | Microbiome Egg Antibody Therapy

The silent pandemic of Antimicrobial Resistance (AMR) is escalating, yet the pipeline for new antibiotics is dangerously dry. Why is there virtually NO investment? In this video, I share my critical insights on the current AMR crisis and the systemic failures leaving us vulnerable.
We dive deep into: 🔍
• The alarming reality of AMR today and why it's a bigger threat than many realize.
• The critical funding gap: Exploring WHY the market has abandoned new antibiotic development, putting global health at risk.
• Introducing a groundbreaking alternative: Discover our company's innovative solution – Microbiome Egg Antibody Therapy (MEGGABIOTICS). Learn how this novel approach targets pathogens without being susceptible to traditional AMR mechanisms, offering a potential lifeline.
But the conversation on public health responsibility doesn't stop there. I also address the recent Kennedy ban prohibiting recommendations of the COVID vaccine for pregnant women and children. In this video, I explain why I agree with this cautious, safety-first approach and the importance of robust, long-term safety data, especially for vulnerable populations.

This is a critical moment for antimicrobial innovation and evidence-based public health policy. We need bold solutions like Microbiome Egg Antibody Therapy to combat AMR, and prudent decision-making regarding medical interventions for sensitive groups.
What are your thoughts on the AMR funding crisis, novel alternatives like egg antibody therapy, or vaccine recommendations? Share your insights in the comments below!

👉 Learn more about our work on Microbiome Egg Antibody Therapy: https://meggabiotics.com/
https://immunimed.com/
👉 Follow us for updates